What makes Hal Barron tick? Look at the people he’s teaming up with at GSK
GSK R&D chief Hal Barron is all about people: The people who lead his teams, the people on his teams and the people he’s collaborating with.
If you listened closely to Barron’s one-year review of the effort to turn around GSK’s R&D organization in their Q2 update this week, that came through loud and clear as he flagged a series of new hires, new plans to build research teams and a new cell therapy collaboration we haven’t heard of before.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.